Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06462963 | OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)(SPRINT) | recruiting | N/A | 302 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Aug 1, 2025 | clinicaltrials |
| NCT06691776 | Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)(FASCINATE) | recruiting | N/A | 100 | The Netherlands Cancer Institute |
| 1 |
| Aug 1, 2025 |
| clinicaltrials |
| NCT07032584 | Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer | recruiting | N/A | 74 | University of UtahOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT02543905 | The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment(PROFILE) | recruiting | — | 1,600 | Institute of Cancer Research, United KingdomOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT05574647 | Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer(IP7-PACIFIC) | recruiting | N/A | 3,600 | Imperial College LondonOTHER | 1 | Jul 24, 2025 | clinicaltrials |
| NCT06666270 | Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors | recruiting | Phase 1 | 30 | Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdINDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT05882253 | Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)(IMAGINED) | recruiting | N/A | 225 | University of California, San DiegoOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT05033301 | Evaluating the Effectiveness of the Nurse Ned Clinic(NurseNed) | recruiting | N/A | 600 | University Health Network, TorontoOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT07057375 | The Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patients Treated With Androgen Deprivation Therapy | recruiting | N/A | 110 | Chinese University of Hong KongOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT05582772 | TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer(TOPCOP3) | recruiting | N/A | 168 | University Health Network, TorontoOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT06776172 | Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0. | recruiting | N/A | 400 | University Hospital, Basel, SwitzerlandOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT06392737 | Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis | recruiting | N/A | 360 | Peking University First HospitalOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07047495 | Personalization of External Beam Radiation Therapy in Localised Tumours(MINIONS) | recruiting | — | 35 | European Institute of OncologyOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT05796973 | Measuring Oncological Value of Exercise and Statin(MOVES) | recruiting | Phase 3 | 240 | Tampere University HospitalOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT07038304 | The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)(OLYMPIAN) | recruiting | Phase 2 | 35 | University Medical Center GroningenOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT04004312 | Single Fractions SBRT for Prostate Cancer | recruiting | N/A | 12 | Fabio CuryOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT04249154 | Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer(PROMPT) | recruiting | Phase 2 | 77 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06769425 | HS-10502 Combination Treatment in Patients With Advanced Solid Tumors(HS-10502) | recruiting | Phase 1 | 157 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 24, 2025 | clinicaltrials |
| NCT05191680 | TherApeutics in Early ProState Cancer (TAPS02) | recruiting | Phase 2 | 90 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Jun 20, 2025 | clinicaltrials |
| NCT06982469 | High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy | recruiting | — | 20 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT06684652 | Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer | recruiting | N/A | 300 | Peking University First HospitalOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT06334809 | INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations(INSIDE) | recruiting | — | 400 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT04340024 | Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | recruiting | — | 5,000 | National Cancer Centre, SingaporeOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06546267 | Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)(PROST-ART) | recruiting | — | 2,500 | IRCCS San RaffaeleOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT05936736 | 24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer(PRO-FAST) | recruiting | N/A | 70 | IRCCS San RaffaeleOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06215508 | Geriatric Assessment and Technology Evaluation in Prostate Cancer | recruiting | — | 120 | University of ChicagoOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT07001709 | Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)(ENABLE) | recruiting | Phase 4 | 29 | Deventer ZiekenhuisOTHER | 1 | Jun 3, 2025 | clinicaltrials |
| NCT06355336 | Real World Prostate Cancer Registry(RWPCR) | recruiting | — | 1,000 | Cincinnati Cancer AdvisorsNETWORK | 1 | May 31, 2025 | clinicaltrials |
| NCT05805436 | Preop Laxatives in Robotic Urologic Surgery | recruiting | Phase 4 | 240 | Chad R. TracyOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT06049355 | EMBRACE: Exercising Together | recruiting | Phase 2 | 400 | OHSU Knight Cancer InstituteOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT01221168 | Epidemiologic and Genetic Study on Familial Prostate Cancer | recruiting | — | 10,000 | Centre de Recherche sur les Pathologies ProstatiquesOTHER | 1 | May 23, 2025 | clinicaltrials |
| NCT05443412 | Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection | recruiting | — | 510 | Chinese University of Hong KongOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06981377 | PRostate Cancer Plasma Integrative Multi-modal Evaluation(PRIME) | recruiting | — | 800 | Santa Chiara HospitalOTHER | 1 | May 20, 2025 | clinicaltrials |
| NCT06977906 | Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes | recruiting | N/A | 300 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT06972628 | Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617 | recruiting | Phase 2 | 30 | Ebrahim S DelpassandOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06971211 | Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC(PARTOM) | recruiting | Phase 2 | 40 | Jianbin BiOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT06139575 | Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer | recruiting | Phase 1 / Phase 2 | 90 | Bivision Pharmaceuticals, Inc.INDUSTRY | 1 | May 13, 2025 | clinicaltrials |
| NCT04186585 | Recommended Dose Estimation of BP-C2 | recruiting | Phase 1 | 8 | MeddocOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT05582876 | Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer(PROSPETMR2021) | recruiting | N/A | 366 | Medical University of BialystokOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT03344835 | Hong Kong Prostate Cancer Study Group Database | recruiting | — | 15,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT03893929 | The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population | recruiting | — | 5,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT03914391 | To Identify Potential New Urine Markers for the Screening of Prostate Cancer | recruiting | — | 10,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT05761093 | Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment | recruiting | — | 306 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06163924 | The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT | recruiting | — | 130 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06262633 | A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer | recruiting | N/A | 103 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06360523 | To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence | recruiting | N/A | 368 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT04503265 | A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | recruiting | Phase 1 / Phase 2 | 122 | AtlasMedx, IncorporatedINDUSTRY | 1 | May 1, 2025 | clinicaltrials |
| NCT05715502 | Focal Salvage Brachytherapy Study (FocaSaBra)(FocaSaBra) | recruiting | N/A | 100 | The Greater Poland Cancer CentreOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT06946771 | Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions | recruiting | — | 500 | Zhen LiOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT06945315 | SAFE Nerve Sparing Guided by Micro-ultrasound (MUS) | recruiting | Phase 3 | 196 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Apr 25, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Aug 1, 2025source: clinicaltrials